dimenhydrinate Tablets 50 mg
Dossier type
CTD
Dossier status
Ready to file
Country of origin
Peru
GMP approvals
WHO
Manufacturer #18811
This Peru-based pharmaceutical manufacturer is dedicated to the commercialization and production of quality medicines for human use, supplying pharmaceutical products across OTC, antibiotic, digestive, pain, gynecological, respiratory, urological, vitamin, and dermatological segments. Operating with high quality standards and Good Manufacturing Practices, it also provides raw materials, packaging materials, quality control, validation of analytical methodologies, and stability studies, supporting the development and reliable supply of pharmaceutical products that meet regulatory requirements and customer needs.
Dimenhydrinate is a pharmaceutical drug that is used to treat insomnia, vertigo and nausea. As a standalone drug, it is primarily marketed as dimenhydrinate tablets but is also available in liquid and suppository form. Depending on the formulation, it is can be administered orally, or by way of either intravenous or intramuscular injection.
Dimenhydrinate is also commonly used as an ingredient in combination drugs, along with substances such as cinnarizine, pyridoxine, paracetamol, and others. Major suppliers of trade name dimenhydrinate medications include Pfizer, Sandoz, and Teva. On the other hand, suppliers Fresenius Kabi, Mylan are few of the distributors of generic versions of the drug.
Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.